In addition, we utilized a BRCA2 knockout human colorectal adenocarcinoma cell line, DLD1 BRCA2 (−/−), which is known to be highly sensitive to PARP inhibition compared to parental cells retaining BRCA223,24. This evidence concerns the gene BRCA2 and colorectal adenocarcinoma.